Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MyMedCards ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   2.1% 6.2% 3.8% 1.7% 1.0% 1.3% 9.2% 9.2%   Credit score (0-100)   69 39 51 71 86 78 27 27   Credit rating   A BBB BBB A A A BB BB   Credit limit (kDKK)   0.1 0.0 0.0 1.3 189.7 66.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   494 1,244 1,560 2,178 3,504 4,808 0.0 0.0   EBITDA   494 56.1 518 933 1,377 1,532 0.0 0.0   EBIT   341 -321 91.4 507 1,027 1,206 0.0 0.0   Pre-tax profit (PTP)   326.2 -324.2 75.7 503.2 1,024.3 1,218.7 0.0 0.0   Net earnings   255.1 -252.9 76.5 392.4 797.9 939.9 0.0 0.0   Pre-tax profit without non-rec. items   326 -324 75.7 503 1,024 1,219 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   918 515 591 984 1,782 2,721 1,460 1,460   Interest-bearing liabilities   122 485 122 120 87.0 36.8 0.0 0.0   Balance sheet total (assets)   1,660 1,639 1,956 2,293 2,990 4,028 1,460 1,460   Net Debt   -94.4 485 -288 -99.7 -1,190 -2,649 -1,460 -1,460     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   494 1,244 1,560 2,178 3,504 4,808 0.0 0.0   Gross profit growth   40.3% 151.8% 25.4% 39.6% 60.9% 37.2% -100.0% 0.0%   Employees   0 3 3 3 4 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 33.3% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,660 1,639 1,956 2,293 2,990 4,028 1,460 1,460   Balance sheet change%   119.2% -1.3% 19.4% 17.3% 30.4% 34.7% -63.7% 0.0%   Added value   493.9 56.1 518.0 933.1 1,453.1 1,532.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   848 -252 -586 -853 -701 -653 -263 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   68.9% -25.8% 5.9% 23.3% 29.3% 25.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.2% -19.4% 5.1% 23.9% 38.9% 34.8% 0.0% 0.0%   ROI %   37.1% -28.2% 9.9% 49.4% 63.4% 50.9% 0.0% 0.0%   ROE %   34.5% -35.3% 13.8% 49.8% 57.7% 41.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   55.3% 31.4% 30.2% 42.9% 59.6% 67.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -19.1% 864.8% -55.5% -10.7% -86.4% -172.9% 0.0% 0.0%   Gearing %   13.3% 94.2% 20.6% 12.2% 4.9% 1.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   23.6% 1.2% 5.5% 4.1% 3.8% 1.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 0.2 0.5 1.2 2.2 3.0 0.0 0.0   Current Ratio   1.8 0.2 0.5 1.2 2.2 3.0 0.0 0.0   Cash and cash equivalent   216.2 0.0 409.5 220.2 1,276.6 2,685.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   118.8 -602.4 -503.9 261.2 1,271.9 2,485.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 19 173 311 363 306 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 19 173 311 344 306 0 0   EBIT / employee   0 -107 30 169 257 241 0 0   Net earnings / employee   0 -84 25 131 199 188 0 0